ScholarIQanswers from OpenAlex
The Nature Conservancy
InstitutionResearch output, impact & collaborations
The Nature Conservancy is a institution indexed in ScholarIQ from OpenAlex.
What is known about The Nature Conservancy?
ScholarIQrecord summary
The Nature Conservancy is a research organisation in Arlington, US. OpenAlex records 18,636 works and 813,487 citations for it. 2,889 researchers list it as their most recent affiliation.
How many works does The Nature Conservancy have?
ScholarIQindexed works
The Nature Conservancy has 18,636 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does The Nature Conservancy have?
ScholarIQcitation count
The Nature Conservancy has 813,487 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at The Nature Conservancy?
ScholarIQresearcher count
The Nature Conservancy has 2,889 researchers in the ScholarIQ index.
What is the average h-index at The Nature Conservancy?
ScholarIQavg h-index
The Nature Conservancy has an average h-index of 74.6 in OpenAlex.
What is the ROR of The Nature Conservancy?
ScholarIQror
The ROR for The Nature Conservancy is on the source record.
What is the OpenAlex record for The Nature Conservancy?
ScholarIQopenalex
The OpenAlex for The Nature Conservancy is on the source record.
What is the Wikidata of The Nature Conservancy?
ScholarIQwikidata
The Wikidata for The Nature Conservancy is on the source record.
Who are the most-cited researchers behind The Nature Conservancy?
ScholarIQtop researchers by citations
What are the most-cited papers on The Nature Conservancy?
ScholarIQmost cited works
Global Biodiversity: Indicators of Recent Declines
Stuart H. M. Butchart, Matt Walpole, Ben Collen, A. van Strien, Jörn P. W. Scharlemann, Rosamunde E. A. Almond, Jonathan Baillie, Bastian Bomhard, Claire Brown, John Bruno, Kent E. Carpenter, Geneviève M. Carr, Janice Chanson, Anna M. Chenery, Jorge Csirke, Nick C. Davidson, Frank Dentener, Matt Foster, Alessandro Galli, James N. Galloway, Piero Genovesi, Richard D. Gregory, Marc Hockings, Valerie Kapos, Jean‐François Lamarque, Fiona Leverington, Jonathan Loh, Mélodie A. McGeoch, Louise McRae, Anahit Minasyan, Monica Hernández Morcillo, Thomasina E. E. Oldfield, Daniel Pauly, Suhel Quader, Carmen Revenga, John R. Sauer, Benjamin Skolnik, Dian Spear, Damon Stanwell‐Smith, Simon N. Stuart, Andy Symes, Megan Tierney, Tristan D. Tyrrell, Jean-Christophe Vié, Reg Watson
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
Robin Kate Kelley, Makoto Ueno, Changhoon Yoo, Richard S. Finn, Junji Furuse, Zhenggang Ren, Thomas Yau, Heinz‐Josef Klümpen, Stephen L. Chan, Masato Ozaka, Chris Verslype, Mohamed Bouattour, Joon Oh Park, Olga Barajas, Uwe Pelzer, Juan W. Valle, Li Yu, Usha Malhotra, Abby B. Siegel, Julien Edeline, Arndt Vogel, Arndt Vogel, Mehmet Akce, Inmaculada Alés Díaz, Gustavo R. Alves, Sumitra Anand, Çağatay Arslan, Jamil Asselah, Eric Assenat, F. Aubin, Li‐Yuan Bai, Yuxian Bai, Olga Barajas, Susan E. Bates, Stephen Begbie, Irit Ben‐Aharon, Nina Beri, Marie‐Luise Berres, Jean‐Frédéric Blanc, Ivan Borbath, Robert Bordonaro, Mohamed Bouattour, Giovanni Brandi, Adam M. Burgoyne, Kritiya Butthongkomvong, Marcos Pedro Guedes Camandaroba, Ke Cao, Marcela Carballido, Jen‐Shi Chen, Jen‐Shi Chen, Ming-Huang Chen, Ashley Cheng, Ashley Cheng, Tai‐Jan Chiu, Hye Jin Choi, Hong Jae Chon, Joëlle Collignon, Antonio Cubillo Gracián, S. Lindsey Davis, Ricardo Saraiva de Carvalho, D.J.A. de Groot, Anne Demols, Judith de Vos, Maria Diab, Jacob C. Easaw, Martin Eatock, Julien Edeline, Rawad Elias, Fredericus Eskens, Alfredo Falcone, Plinio Fernández, Richard Finn, Fábio Franke, Masayuki Furukawa, Junji Furuse, Olumide B. Gbolahan, Karen Geboes, Keri-Lee Geneser, Zhimin Geng, Ravit Geva, Roopinder Gillmore, Thorsten Oliver Goetze, Hongfeng Gou, Julieta Grasselli, Shanzhi Gu, Mahmut Gümüş, Nadia Haj Mohammad, Chunyi Hao, Hakan Harputluoğlu, Hassan Hatoum, Volker Heinemann, Wang Kwong Ho, Chiun Hsu, Ayala Hubert, Jun‐Eul Hwang, Mevlüde İnanç, Soledad Iseas, Vaishnavi Jeyasingam, Paula Jiménez Fonseca, Warren Joubert
Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin
Peng Zhou, Hang Fan, Tian Lan, Xing‐Lou Yang, Weifeng Shi, Wei Zhang, Yan Zhu, Yawei Zhang, Qingmei Xie, Shailendra Mani, Xiao-Shuang Zheng, Bei Li, Jin-Man Li, Hua Guo, Guangqian Pei, Xiaoping An, Junwei Chen, Ling Zhou, Kaijie Mai, Zixian Wu, Di Li, Danielle E. Anderson, Libiao Zhang, Shiyue Li, Zhiqiang Mi, Tong-Tong He, Feng Cong, Pengju Guo, Ren Huang, Yun Luo, Xiangling Liu, Jing Chen, Yong Huang, Qiang Sun, Xianglilan Zhang, Yuanyuan Wang, Shaozhen Xing, Yanshan Chen, Yuan Sun, Juan Li, Peter Daszak, Lin‐Fa Wang, Zheng‐Li Shi, Yigang Tong, Jingyun Ma
Prognostic Factors in Advanced Cancer Patients: Evidence-Based Clinical Recommendations—A Study by the Steering Committee of the European Association for Palliative Care
Marco Maltoni, Augusto Caraceni, Cinzia Brunelli, Bert Broeckaert, Nicholas A. Christakis, Steffen Eychmueller, Paul Glare, María Nabal, Antonio Viganò, Philip Larkin, Franco De Conno, Geoffrey Hanks, Stein Kaasa
Leopard (<i>Panthera pardus</i>) status, distribution, and the research efforts across its range
Andrew P. Jacobson, Peter Gerngross, Joseph Lemeris, Rebecca F. Schoonover, Corey Anco, Christine Breitenmoser‐Würsten, Sarah M. Durant, Mohammad S. Farhadinia, Philipp Henschel, Jan F. Kamler, Alice Laguardia, Susana Rostro‐García, Andrew Stein, Luke Dollar
How much of the research on The Nature Conservancy is open access?
ScholarIQopen access share
67%OPEN ACCESS